DE60325976D1 - Abreicherung von plasmaproteinen - Google Patents

Abreicherung von plasmaproteinen

Info

Publication number
DE60325976D1
DE60325976D1 DE60325976T DE60325976T DE60325976D1 DE 60325976 D1 DE60325976 D1 DE 60325976D1 DE 60325976 T DE60325976 T DE 60325976T DE 60325976 T DE60325976 T DE 60325976T DE 60325976 D1 DE60325976 D1 DE 60325976D1
Authority
DE
Germany
Prior art keywords
affinity
methods
abundance
interest
depletion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325976T
Other languages
English (en)
Inventor
Gregory E Rice
Mark S Baker
Michael Quinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HealthLinx Ltd
Original Assignee
HealthLinx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27671561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60325976(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by HealthLinx Ltd filed Critical HealthLinx Ltd
Application granted granted Critical
Publication of DE60325976D1 publication Critical patent/DE60325976D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G01N30/14—Preparation by elimination of some components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N2030/009—Extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60325976T 2002-08-23 2003-08-22 Abreicherung von plasmaproteinen Expired - Lifetime DE60325976D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002951240A AU2002951240A0 (en) 2002-08-23 2002-08-23 Depletion of plasma proteins
PCT/AU2003/001075 WO2004019009A1 (en) 2002-08-23 2003-08-22 Depletion of plasma proteins

Publications (1)

Publication Number Publication Date
DE60325976D1 true DE60325976D1 (de) 2009-03-12

Family

ID=27671561

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60325976T Expired - Lifetime DE60325976D1 (de) 2002-08-23 2003-08-22 Abreicherung von plasmaproteinen

Country Status (8)

Country Link
US (2) US20090035849A1 (de)
EP (1) EP1540304B2 (de)
AT (1) ATE421684T1 (de)
AU (1) AU2002951240A0 (de)
DE (1) DE60325976D1 (de)
DK (1) DK1540304T4 (de)
ES (1) ES2322804T5 (de)
WO (1) WO2004019009A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951240A0 (en) 2002-08-23 2002-09-19 Royal Women's Hospital Depletion of plasma proteins
AU2006273702A1 (en) * 2005-07-28 2007-02-01 Biosystems International Sas Normalization of complex analyte mixtures
WO2007024825A2 (en) * 2005-08-26 2007-03-01 Genway Biotech, Inc. Immunoaffinity separation and analysis compositions and methods
WO2008058325A1 (en) * 2006-11-13 2008-05-22 Healthlinx Limited Immunoaffinity compositions for immunodepletion of proteins
US20080227112A1 (en) * 2007-03-12 2008-09-18 Genetel Laboratories Llc Global polyclonal antibodies, process for depleting commonly shared proteins by same, devices using same
US9388243B2 (en) 2013-05-29 2016-07-12 Samsung Electronics Co., Ltd. Method of target membrane protein depletion
EP3102637B1 (de) * 2014-02-04 2018-04-11 Basf Se Reinigungsverfahren für antikörper, antikörperfragmente oder manipulierte varianten davon mit spezifischen anthrachinon-farbstoffligandenstrukturen
EP2918641A1 (de) * 2014-03-13 2015-09-16 Basf Se Reinigungsverfahren für Antikörper, Antikörperfragmente oder manipulierte Varianten davon mit spezifischen Anthrachinon-Farbstoffligandenstrukturen
EP4038349A4 (de) * 2019-10-01 2022-12-28 Repligen Corporation Bestimmung der proteinkonzentration in einer flüssigkeit
CN112485452B (zh) * 2020-12-08 2023-10-10 北京工业大学 金属团簇作为人工抗体定量蛋白丰度的方法
CN114593979A (zh) * 2022-04-01 2022-06-07 清华大学 一种基于质谱检测体液样本里中低丰度蛋白的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056737A (en) * 1976-09-07 1977-11-01 Bell Telephone Laboratories, Incorporated Anti-aliasing pre-filter circuit for semiconductor charge transfer device
JPS5486602A (en) * 1977-10-27 1979-07-10 Hoffmann La Roche Production of purified alpha 1 phetoprotein
US4550019A (en) * 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
CH660634A5 (de) * 1983-08-30 1987-05-15 Dimitrios Giannitsis Verfahren zur herstellung von natuerlichem immunoadsorbens.
US4962189A (en) * 1985-06-20 1990-10-09 Cetus Corportion Ribotoxin conjugates
JPH06103308B2 (ja) * 1987-11-06 1994-12-14 株式会社東芝 免疫分析方法
JP3155961B2 (ja) * 1987-12-30 2001-04-16 煕 中島 抗ビリルビンモノクローナル抗体固定担体およびその製造方法
US6287793B1 (en) * 1988-08-19 2001-09-11 Elan Pharmaceuticals, Inc. Diagnostic methods for alzheimer's disease
DE4221569A1 (de) * 1992-07-01 1994-01-05 Alloy Tech Ag Vaduz Spüleinrichtung zum selbsttätigen Spülen eines leergelaufenen Flüssigkeitsspeicherraumes, insbesondere eines Regenbeckens oder eines Kanalstauraumes
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
US5420253A (en) * 1993-09-09 1995-05-30 Willmar Poultry Company, Inc. Method for purifying egg yolk immunoglobulins
DE19528029B4 (de) * 1995-07-31 2008-01-10 Chemagen Biopolymer-Technologie Aktiengesellschaft Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung
DE19650991A1 (de) * 1996-11-26 1998-06-04 Ruediger Dr Schade Neue Proteine Y, Verfahren zu ihrer Herstellung und ihre Verwendung
US6969601B2 (en) * 1997-04-03 2005-11-29 Jensenius Jens Chr MASP-2, a complement-fixing enzyme, and uses for it
US6410692B2 (en) * 1998-02-02 2002-06-25 Novadx, Inc. Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
GB9811656D0 (en) 1998-05-29 1998-07-29 Oxford Glycosciences Uk Ltd Gels, methods and apparatus for identification and characterization of biomolecules
US7691645B2 (en) * 2001-01-09 2010-04-06 Agilent Technologies, Inc. Immunosubtraction method
US20030032017A1 (en) 2001-08-03 2003-02-13 Large Scale Proteomics, Corp. Quantification of low molecular weight and low abundance proteins using high resolution two-dimensional electrophoresis and mass spectrometry
AU2002951240A0 (en) 2002-08-23 2002-09-19 Royal Women's Hospital Depletion of plasma proteins

Also Published As

Publication number Publication date
US20090035849A1 (en) 2009-02-05
ATE421684T1 (de) 2009-02-15
EP1540304A4 (de) 2006-10-04
ES2322804T3 (es) 2009-06-29
AU2002951240A0 (en) 2002-09-19
EP1540304A1 (de) 2005-06-15
EP1540304B1 (de) 2009-01-21
WO2004019009A1 (en) 2004-03-04
US9417218B2 (en) 2016-08-16
EP1540304B2 (de) 2012-08-15
ES2322804T5 (es) 2012-11-07
DK1540304T4 (da) 2012-11-26
DK1540304T3 (da) 2009-05-25
US20110008900A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
Leo et al. Proteomic strategies for the identification of proteinaceous binders in paintings
ATE315105T1 (de) Nucleinsauremoleküle mit spezifischer erkennung von nativem prpsc, herstellung und verwendung
WO2004072228A3 (en) Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
DE602004018388D1 (de) Proteinphosphorylierung bei grosszellig-anaplastischem lymphom
DE60231651D1 (de) Proteinreinigungsverfahren
DE60325976D1 (de) Abreicherung von plasmaproteinen
CA2557997A1 (en) Determination of analyte characteristics based upon binding properties
WO2002010740A3 (en) Quantitative analysis of hexose-monophosphates from biological samples
Zabzdyr et al. New approaches to single-cell analysis by capillary electrophoresis
KR20210116502A (ko) 항체 단편화를 동정 및 정량화하는 방법 및 시스템
Yates et al. Direct analysis of proteins in mixtures: application to protein complexes
ATE392621T1 (de) Verfahren zur quantifizierung von glykiertem protein
Stone et al. Use of liquid chromatography‐electrospray ionization‐tandem mass spectrometry (LC‐ESI‐MS/MS) for routine identification of enzymatically digested proteins separated by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis
DE50105263D1 (de) Verfahren zur analyse von proteinen
MX2022012831A (es) Sistemas y metodos para evaluar moleculas grandes con sensibilidad mejorada.
BRPI0406265B8 (pt) método para análise por eletroforese capilar, método para pesquisa e tipagem de proteínas monoclonais, método de preparação de anticorpos modificados sobrecarregados negativamente e kit para detecção e tipagem de proteínas monoclonais
DK1388007T3 (da) Fremgangsmåde til kvalitativ og/eller kvantitativ bestemmelse af slægt, art, race og/eller geografisk oprindelse af biologiske materialer
Blonder et al. Proteomic investigation of natural killer cell microsomes using gas-phase fractionation by mass spectrometry
Lacher et al. Development of a capillary gel electrophoresis method for monitoring disulfide isomer heterogeneity in IgG2 antibodies
US20090256068A1 (en) Solution fragmentation systems and processes for proteomics analysis
Wasinger et al. Two‐dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow™ fractionated native human plasma
Shabanowitz et al. Sequencing the primordial soup
Novotny Recent advances in the isolation and structural studies of biomacromolecules using microcolumn techniques
WO2002029414A3 (en) A method for the quantitative determination of one or more compounds
WO2008150091A3 (en) Novel analytical method for protein

Legal Events

Date Code Title Description
8363 Opposition against the patent
R102 Epo decision maintaining patent in amended form now final

Ref document number: 1540304

Country of ref document: EP

Effective date: 20120815